[{"data":1,"prerenderedAt":47},["ShallowReactive",2],{"q-nurse-108-2-medical-surgical-052":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":23},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"freq":22},"nurse-108-2-內外科護理學-052","nurse-108-2-medical-surgical-052",108,2,52,"肺栓塞病人使用肝素以阻止新的血塊形成，通常須維持部分凝血活酶時間（aPTT）為正常值的多少倍？",{"A":14,"B":15,"C":16,"D":17},"1.0～1.4","1.5～2.5","2.6～3.5","3.6～4.5 代號：3106 頁次：6－5","B",null,[],"本題考點為 heparin 抗凝治療的實驗室監測指標與治療範圍。heparin 主要延長內在凝血途徑，臨床以部分凝血活酶時間(aPTT)監測，治療劑量的目標是維持 aPTT 為正常對照值的 1.5～2.5 倍，此區間可有效抗凝又不過度增加出血風險，故選 B。選項 A 的 1.0～1.4 倍幾乎等同未達治療濃度，抗凝不足、血栓仍可能延伸。選項 C 的 2.6～3.5 倍與 D 的 3.6～4.5 倍皆超過治療上限，會顯著提高出血併發症風險，屬於過度抗凝。因此以安全與療效兼顧的 1.5～2.5 倍為標準答案。",1,[24,28,31,35,39,43],{"webId":25,"stem":26,"number":22,"year":27,"session":22},"nurse-106-1-medical-surgical-001","有關巴金森氏病治療之敘述，下列何者正確？",106,{"webId":29,"stem":30,"number":10,"year":27,"session":22},"nurse-106-1-medical-surgical-002","有關巴金森氏病的護理指導，下列何者正確？",{"webId":32,"stem":33,"number":34,"year":27,"session":22},"nurse-106-1-medical-surgical-003","下列何者為出血性腦中風最主要的危險因子？",3,{"webId":36,"stem":37,"number":38,"year":27,"session":22},"nurse-106-1-medical-surgical-004","有關頸部脊髓損傷的神經性休克徵象，下列何者正確？",4,{"webId":40,"stem":41,"number":42,"year":27,"session":22},"nurse-106-1-medical-surgical-005","陳小姐診斷為腦下垂體腫瘤，進行經蝶骨腦下垂體切除術，術後出現尿崩症，下列敘述何者錯誤？",5,{"webId":44,"stem":45,"number":46,"year":27,"session":22},"nurse-106-1-medical-surgical-006","顱底骨折常出現的徵象，下列何者錯誤？",6,1783840759200]